​

 

McGivney Global Advisors has developed unique and proprietary modeling methodologies to help you understand the potential impact of the evolving health care environment, from Alternative Payment Models (APMs) portfolio impact modeling to specific coverage policy or utilization management decisions by public (Medicare and Medicaid) or leading private and commercial payers and managed care companies.

 

Our team has built financial impact assessment models and long-term revenue forecasts for leading pharmaceutical companies, forecasting the impact of policy changes on specific products, portfolios, and therapeutic areas. We have developed models to help leading specialty brands understand the potential revenue impact of commercial coverage decisions interpreting how payment methodology changes may impact sales. Our payer-based forecast scenarios and revenue projections can help you better understand how your products will perform in today's shifting healthcare landscape and in the reasonable near future.

 

We are experts in building dynamic, responsive models that incorporate expert stakeholder points of view and help your team make crucial business decisions when future policy outcomes are ambiguous. We provide you with the tools to take action and plan for scenarios that are likely to change the prescribing behavior of key customer groups practicing across diverse settings (e.g. academic centers, community practices).